| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Former Chief Medical Officer | Chief Medical Officer
1 company
Priti Patel last filed a Form 4 in March 2023, as Former Chief Medical Officer at NGNE. Priti Patel's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
Historically, Priti Patel's trades have earned a below-average insider score of 32/100 across 3 rated trades. Over a 12-month horizon, 33.3% of those trades were profitable, with an average 12-month return of -57.6%.
At the last filing, the largest reported position was 37,313 shares of NGNE. The NGNE filings lean toward selling, a net 23,687 shares.
Priti Patel has 7 Form 4 filings on record from April 2021 to March 2023, all as Former Chief Medical Officer at Neurogene (NGNE), 2021–2023.
The 11 reported transactions were 5 option or other derivative awards, 3 option exercises and 3 open-market sales.
Counted by filing, the open-market trades come to no purchases and 3 sales worth about $18K.
The largest open-market sale was 14,380 shares of NGNE at an average $0.60 on February 2, 2023, about $9K. Twelve months later NGNE was up 168%.
Shares as reported in the last Form 4 for each company; the most recent is from March 2023. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 3, 2023 | NGNE Neurogene Inc. | Former Chief Medical Officer | Sale+OE | 3,769 | $0.69 | $2,607.77 | -9.2% | +17.9% | +218.5% | |
| Feb 2, 2023 | NGNE Neurogene Inc. | Chief Medical Officer | Sale+OE | 14,380 | $0.60 | $8,587.74 | -31.6% | +52.2% | +167.8% | |
| May 2, 2022 | NGNE Neurogene Inc. | Chief Medical Officer | Sale+OE | 5,538 | $1.22 | $6,748.61 | -46.2% | -20.0% | -27.2% |